Investigates the role of lipoprotein abnormalities in the development of progressive nondiabetic renal disease. Rate of decline in renal function in relation to high and low levels of apolipoprotein B; Effect of hypolipemic drugs on renal dyslipidemia; Mechanism in the progression of renal insufficiency.